UBS Group
MXIM

UBS Group’s Maxim Integrated Products MXIM Stock Holding History

UBS Group’s Portfolio MXIM Stock Details MXIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-200
Closed -$12K – 8378
2018
Q1 		$12K Buy
+200
New +$11.9K ﹤0.01% 6781
2016
Q1 		– Sell
-66,700
Closed -$2.54M – 8404
2015
Q4 		$2.54M Buy
66,700
+65,700
+6,570% +$2.51M ﹤0.01% 2583
2015
Q3 		$33K Hold
1,000
– – ﹤0.01% 6215
2015
Q2 		$35K Sell
1,000
-100
-9% -$3.42K ﹤0.01% 6345
2015
Q1 		$38K Sell
1,100
-900
-45% -$30.7K ﹤0.01% 6308
2014
Q4 		$64K Buy
+2,000
New +$58.8K ﹤0.01% 6187

Other funds holding MXIM

CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
RP
Rowlandmiller & Partners Atlanta, Georgia $549M AUM 36.2% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

UBS Group's MXIM Position: Q3 2021 in Review

UBS Group sold out of Maxim Integrated Products (MXIM) in Q3 2021, closing a stake of 377,796 shares — an estimated $39.8M sold.

UBS Group first reported a position in MXIM in Q4 2014 and held it in 27 quarters. The position peaked at $63.5M in Q4 2020. 3 funds tracked by Wall St. Rank hold MXIM as of Q3 2021.

  • UBS Group reported no remaining Maxim Integrated Products position as of Q3 2021 after selling out during the quarter.
  • UBS Group sold 377,796 Maxim Integrated Products shares in Q3 2021, an estimated $39.8M.
  • UBS Group first reported a position in Maxim Integrated Products in Q4 2014 and held it in 27 quarters.
  • UBS Group's Maxim Integrated Products position peaked at $63.5M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.